Cargando…
The Long and Short of Tamoxifen Therapy: A Review of the ATLAS Trial
Review of "Long term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial" by Davies et al. (2013), Lancet, 381, 805–816. For another perspective on the ATLAS trial, please se...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093467/ https://www.ncbi.nlm.nih.gov/pubmed/25032035 |